{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:33:03Z","timestamp":1792481583292,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100018231","name":"Aligning Science Across Parkinson's","doi-asserted-by":"publisher","award":["ASAP-020505"],"award-info":[{"award-number":["ASAP-020505"]}],"id":[{"id":"10.13039\/100018231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018231","name":"Aligning Science Across Parkinson's","doi-asserted-by":"publisher","award":["ASAP-020505"],"award-info":[{"award-number":["ASAP-020505"]}],"id":[{"id":"10.13039\/100018231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2023-127802OB-I00"],"award-info":[{"award-number":["PID2023-127802OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    There is a pressing need for the development, characterization, and standardization of animal models of Parkinson\u2019s disease (PD) that properly mimic the cardinal features of this disorder, comprising both the motor phenotype and neuropathological signatures. In the past few years, animal modeling has moved from neurotoxin-based approaches toward viral vectors carrying a given genetic payload of interest. Here, to induce pigmentation of the mouse brain upon systemic delivery, we took advantage of a modified adeno-associated viral vector capsid engineered to bypass the blood-brain barrier and coding for the human tyrosinase gene (AAV9-P31-\n                    <jats:italic>hTyr<\/jats:italic>\n                    ). Obtained results revealed an ongoing pigmentation of catecholaminergic centers related to the pathophysiology of PD, such as the substantia nigra pars compacta, ventral tegmental area, and locus coeruleus. Moreover, pigmented dopaminergic neurons exhibited Lewy body-like intracytoplasmic inclusions, a progressive nigrostriatal degeneration, and a time-dependent PD motor phenotype. The bilateral pigmented model of PD generated in this way does not require stereotactic surgery for viral vector delivery, opening up unprecedented possibilities for preclinical testing of therapeutic candidates designed to reduce disease progression rates.\n                  <\/jats:p>","DOI":"10.1038\/s41531-026-01289-9","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T09:37:33Z","timestamp":1770802653000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Introducing PIGMO, a novel PIGmented MOuse model of Parkinson\u2019s disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Julia","family":"Chocarro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Marana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Espelosin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto J.","family":"Rico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goiaz","family":"Ariznabarreta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Lorenzo-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario M.","family":"Ilarduya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Hernandez-Alcoceba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Chill\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H.","family":"Kordower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony H. V.","family":"Schapira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Garcia-Osta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria del Mar","family":"Cuadrado-Tejedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L.","family":"Lanciego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"1289_CR1","doi-asserted-by":"publisher","first-page":"e0171790","DOI":"10.1371\/journal.pone.0171790","volume":"12","author":"CJ Zeiss","year":"2017","unstructured":"Zeiss, C. J., Allore, H. G. & Beck, A. P. Established patterns of animal study design undermine translation of disease-modifying therapies for Parkinson\u2019s disease. PLoS ONE 12, e0171790 (2017).","journal-title":"PLoS ONE"},{"key":"1289_CR2","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1084\/jem.20182042","volume":"215","author":"RM Ransohoff","year":"2018","unstructured":"Ransohoff, R. M. All (animal) models (of neurodegeneration) are wrong. Are they also useful? J. Exp. Med. 215, 2955\u20132958 (2018).","journal-title":"J. Exp. Med."},{"key":"1289_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00702-017-1720-0","volume":"125","author":"DJ Marmion","year":"2018","unstructured":"Marmion, D. J. & Kordower, J. H. \u03b1-Synuclein nonhuman primate models of Parkinson\u2019s disease. J. Neural Transm. (Vienna) 125, 385\u2013400 (2018).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"1289_CR4","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3233\/JPD-202200","volume":"10","author":"RA Baker","year":"2020","unstructured":"Baker, R. A. & Bj\u00f6rklund, A. Animal models of Parkinson\u2019s disease: are they useful or not? J. Parkinsons Dis. 10, 1335\u20131342 (2020).","journal-title":"J. Parkinsons Dis."},{"key":"1289_CR5","doi-asserted-by":"publisher","first-page":"695718","DOI":"10.3389\/fnagi.2021.695718","volume":"13","author":"M Shadrina","year":"2021","unstructured":"Shadrina, M. & Slominsky, P. Modeling Parkinson\u2019s disease: not only rodents? Front. Aging Neurosci. 13, 695718 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"1289_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/brainsci14020151","volume":"14","author":"A Sturchio","year":"2024","unstructured":"Sturchio, A. et al. Recalibrating the why and whom of animal models in Parkinson disease: a clinician\u2019s perspective. Brain Sci. 14, 151 (2024).","journal-title":"Brain Sci."},{"key":"1289_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.4103\/NRR.NRR-D-24-00896","volume":"21","author":"J Chocarro","year":"2026","unstructured":"Chocarro, J. & Lanciego, J. L. Adeno-associated viral vectors for modeling Parkinson\u2019s disease in non-human primates. Neural Regen. Res. 21, 224\u2013232 (2026).","journal-title":"Neural Regen. Res."},{"key":"1289_CR8","first-page":"a041612","volume":"15","author":"E Bezard","year":"2025","unstructured":"Bezard, E. et al. Modeling Parkinson\u2019s disease in primates. Cold Spring Harb. Perspect. Med. 15, a041612 (2025).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"1289_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08858-y","volume":"10","author":"I Carballo-Carbajal","year":"2019","unstructured":"Carballo-Carbajal, I. et al. Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson\u2019s disease pathogenesis. Nat. Commun. 10, 973 (2019).","journal-title":"Nat. Commun."},{"key":"1289_CR10","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1093\/brain\/awad331","volume":"146","author":"J Chocarro","year":"2023","unstructured":"Chocarro, J. et al. Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates. Brain 146, 5000\u20135014 (2023).","journal-title":"Brain"},{"key":"1289_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53168-7","volume":"15","author":"A Laguna","year":"2024","unstructured":"Laguna, A. et al. Modelling human neuronal catecholaminergic pigmentation in rodents recapitulates age-related neurodegenerative deficits. Nat. Commun. 15, 8819 (2024).","journal-title":"Nat. Commun."},{"key":"1289_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/334345a0","volume":"334","author":"EC Hirsch","year":"1988","unstructured":"Hirsch, E. C., Graybiel, A. M. & Agid, Y. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson\u2019s disease. Nature 334, 345\u2013348 (1988).","journal-title":"Nature"},{"key":"1289_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1600-0404.1989.tb01778.x","volume":"126","author":"EC Hirsch","year":"1989","unstructured":"Hirsch, E. C., Graybiel, A. M. & Agid, Y. Selective vulnerability of pigmented dopaminergic neurons in Parkinson\u2019s disease. Acta Neurol. Scand. 126, 19\u201322 (1989).","journal-title":"Acta Neurol. Scand."},{"key":"1289_CR14","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1111\/j.1471-4159.1992.tb08350.x","volume":"59","author":"A Kastner","year":"1992","unstructured":"Kastner, A. et al. Is the vulnerability of neurons in the substantia nigra of patients with Parkinson\u2019s disease related to their neuromelanin content? J. Neurochem. 59, 1080\u20131089 (1992).","journal-title":"J. Neurochem."},{"key":"1289_CR15","doi-asserted-by":"publisher","first-page":"105965","DOI":"10.1016\/j.parkreldis.2023.105965","volume":"119","author":"MH Flores-Torres","year":"2024","unstructured":"Flores-Torres, M. H. et al. Hair color, family history of melanoma, and the risk of Parkinson\u2019s disease: an analysis update. Parkinsonism Relat. Disord. 119, 105965 (2024).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1289_CR16","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/mds.28655","volume":"36","author":"DN Dean","year":"2021","unstructured":"Dean, D. N. & Lee, J. C. Linking Parkinson\u2019s disease and melanoma: interplay between \u03b1-synuclein and Pmel17 amyloid formation. Mov. Disord. 36, 1489\u20131498 (2021).","journal-title":"Mov. Disord."},{"key":"1289_CR17","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/2211-5463.12078","volume":"6","author":"G Kramer","year":"2016","unstructured":"Kramer, G. et al. Elevation of glycoprotein nonmetastatic melanoma protein B in type 1 Gaucher disease patients and mouse models. FEBS Open Bio 6, 902\u2013913 (2016).","journal-title":"FEBS Open Bio"},{"key":"1289_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bcmd.2016.12.002","volume":"68","author":"V Murugesan","year":"2018","unstructured":"Murugesan, V. et al. Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease. Blood Cells Mol. Dis. 68, 47\u201353 (2018).","journal-title":"Blood Cells Mol. Dis."},{"key":"1289_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/mds.27583","volume":"34","author":"F Blandini","year":"2019","unstructured":"Blandini, F. et al. Glucocerebrosidase mutations and synucleinopathies: toward a model of precision medicine. Mov. Disord. 34, 9\u201321 (2019).","journal-title":"Mov. Disord."},{"key":"1289_CR20","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.omtm.2020.12.006","volume":"20","author":"M Nonnenmacher","year":"2020","unstructured":"Nonnenmacher, M. et al. Rapid evolution of blood\u2013brain-barrier-penetrating AAV capsids by RNA-driven biopanning. Mol. Ther Methods Clin. Dev. 20, 366\u2013378 (2020).","journal-title":"Mol. Ther Methods Clin. Dev."},{"key":"1289_CR21","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41434-024-00466-w","volume":"31","author":"M Bunuales","year":"2024","unstructured":"Bunuales, M. et al. Characterization of brain transduction capability of a BBB-penetrant AAV vector in mice, rats and macaques reveals differences in expression profiles. Gene Ther. 31, 455\u2013466 (2024).","journal-title":"Gene Ther."},{"key":"1289_CR22","doi-asserted-by":"crossref","unstructured":"Shay, T. F. et al. Primate-conserved carbonic anhydrase IV and murine-restricted LY6C1 enable blood\u2013brain barrier crossing by engineered viral vectors. Sci. Adv. 9, eadg6618 (2023).","DOI":"10.1126\/sciadv.adg6618"},{"key":"1289_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"1289_CR24","doi-asserted-by":"publisher","first-page":"III\/1","DOI":"10.1007\/s00415-002-1301-4","volume":"249","author":"H Braak","year":"2002","unstructured":"Braak, H. et al. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson\u2019s disease (preclinical and clinical stages). J. Neurol. 249, III\/1\u2013III\/5 (2002).","journal-title":"J. Neurol."},{"key":"1289_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nbt.3440","volume":"34","author":"BE Deverman","year":"2016","unstructured":"Deverman, B. E. et al. Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain. Nat. Biotechnol. 34, 204\u2013209 (2016).","journal-title":"Nat. Biotechnol."},{"key":"1289_CR26","doi-asserted-by":"publisher","first-page":"e0225206","DOI":"10.1371\/journal.pone.0225206","volume":"14","author":"Q Huang","year":"2019","unstructured":"Huang, Q. et al. Delivering genes across the blood\u2013brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids. PLoS ONE 14, e0225206 (2019).","journal-title":"PLoS ONE"},{"key":"1289_CR27","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.ymthe.2019.02.013","volume":"27","author":"J Hordeaux","year":"2019","unstructured":"Hordeaux, J. et al. The GPI-linked protein LY6A drives AAV-PHP.B transport across the blood\u2013brain barrier. Mol. Ther. 27, 912\u2013921 (2019).","journal-title":"Mol. Ther."},{"key":"1289_CR28","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.ymthe.2018.01.018","volume":"26","author":"J Hordeaux","year":"2018","unstructured":"Hordeaux, J. et al. The neurotropic properties of AAV-PHP.B are limited to C57BL\/6\u2009J mice. Mol. Ther. 26, 664\u2013668 (2018).","journal-title":"Mol. Ther."},{"key":"1289_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.neulet.2017.11.049","volume":"665","author":"Y Matsuzaki","year":"2018","unstructured":"Matsuzaki, Y. et al. Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain. Neurosci. Lett. 665, 182\u2013188 (2018).","journal-title":"Neurosci. Lett."},{"key":"1289_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1089\/hum.2019.186","volume":"1\u20132","author":"AR Batista","year":"2020","unstructured":"Batista, A. R. et al. Ly6a differential expression in blood\u2013brain barrier is responsible for strain specific central nervous system transduction profile of AAV-PHP.B. Hum. Gene Ther. 1\u20132, 90\u2013102 (2020).","journal-title":"Hum. Gene Ther."},{"key":"1289_CR31","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.7150\/thno.46992","volume":"11","author":"B-S Xie","year":"2021","unstructured":"Xie, B.-S. et al. Low-density lipoprotein receptor, and immune cells control blood-brain barrier penetration by AAV-PHP.eB in mice. Theranostics 11, 1177\u20131191 (2021).","journal-title":"Theranostics"},{"key":"1289_CR32","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.ymthe.2025.01.049","volume":"33","author":"M Garcia-Gomara","year":"2025","unstructured":"Garcia-Gomara, M. et al. FKBP5 inhibition ameliorates neurodegeneration and motor dysfunction in the neuromelanin-SNCA mouse model of Parkinson\u2019s disease. Mol. Ther. 33, 895\u2013916 (2025).","journal-title":"Mol. Ther."},{"key":"1289_CR33","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00702-013-1062-5","volume":"120","author":"O Karlsson","year":"2013","unstructured":"Karlsson, O. & Lindquist, N. G. Melanin affinity and its possible role in neurodegeneration. J. Neural Transm. (Vienna) 120, 1623\u20131630 (2013).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"1289_CR34","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4103\/1673-5374.202928","volume":"12","author":"RL Haining","year":"2017","unstructured":"Haining, R. L. & Achat-Mendes, C. Neuromelanin, one of the most overlooked molecules in modern medicine, is not a spectator. Neural Regen. Res. 12, 373\u2013375 (2017).","journal-title":"Neural Regen. Res."},{"key":"1289_CR35","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1126\/science.3080808","volume":"231","author":"RJ D\u2019Amato","year":"1986","unstructured":"D\u2019Amato, R. J., Lipman, Z. P. & Snyder, S. H. Selectivity of the Parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin. Science 231, 987\u2013989 (1986).","journal-title":"Science"},{"key":"1289_CR36","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/j.1471-4159.2012.07734.x","volume":"121","author":"X Wang","year":"2012","unstructured":"Wang, X. et al. Parkinson\u2019s disease-associated DJ-1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction. J. Neurochem. 121, 830\u2013839 (2012).","journal-title":"J. Neurochem."},{"key":"1289_CR37","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1093\/brain\/awac445","volume":"146","author":"M Gonzalez-Sepulveda","year":"2023","unstructured":"Gonzalez-Sepulveda, M. et al. In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson\u2019s disease. Brain 146, 1040\u20131052 (2023).","journal-title":"Brain"},{"key":"1289_CR38","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.tins.2016.09.003","volume":"39","author":"NP Visanji","year":"2016","unstructured":"Visanji, N. P. et al. \u03b1-Synuclein-based animal models of Parkinson\u2019s disease: challenges and opportunities in a new era. Trends Neurosci. 39, 750\u2013762 (2016).","journal-title":"Trends Neurosci."},{"key":"1289_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/bs.pbr.2020.02.003","volume":"252","author":"MA Cenci","year":"2020","unstructured":"Cenci, M. A. & Bj\u00f6rklund, A. Animal models for preclinical Parkinson\u2019s research: an update and critical appraisal. Prog. Brain Res. 252, 27\u201359 (2020).","journal-title":"Prog. Brain Res."},{"key":"1289_CR40","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.3390\/biomedicines10123026","volume":"10","author":"TD Zhang","year":"2022","unstructured":"Zhang, T. D. et al. How well do rodent models of Parkinson\u2019s disease recapitulate early non-motor phenotypes? A systematic review. Biomedicines 10, 3026 (2022).","journal-title":"Biomedicines"},{"key":"1289_CR41","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3233\/JPD-240207","volume":"14","author":"A Bj\u00f6rklund","year":"2024","unstructured":"Bj\u00f6rklund, A. & Mattsson, B. The AAV-\u03b1-synuclein model of Parkinson\u2019s disease: an update. J. Parkinsons Dis. 14, 1077\u20131094 (2024).","journal-title":"J. Parkinsons Dis."},{"key":"1289_CR42","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3390\/biomedicines9070812","volume":"9","author":"G Bastioli","year":"2021","unstructured":"Bastioli, G. et al. Animal models of autosomal recessive Parkinsonism. Biomedicines 9, 812 (2021).","journal-title":"Biomedicines"},{"key":"1289_CR43","doi-asserted-by":"publisher","first-page":"176819","DOI":"10.1016\/j.ejphar.2024.176819","volume":"980","author":"R Lal","year":"2024","unstructured":"Lal, R., Subgh, A., Watts, S. & Chopra, K. Experimental models of Parkinson\u2019s disease: challenges and opportunities. Eur. J. Pharmacol. 980, 176819 (2024).","journal-title":"Eur. J. Pharmacol."},{"key":"1289_CR44","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1073\/pnas.0605208103","volume":"104","author":"MI Ekstrand","year":"2007","unstructured":"Ekstrand, M. I. et al. Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc. Natl. Acad. Sci. USA 104, 1325\u20131330 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1289_CR45","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","volume":"599","author":"P Gonzalez-Rodriguez","year":"2021","unstructured":"Gonzalez-Rodriguez, P. et al. Disruption of mitochondrial complex I induces progressive Parkinsonism. Nature 599, 650\u2013656 (2021).","journal-title":"Nature"},{"key":"1289_CR46","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00401-019-02023-x","volume":"138","author":"M Wegrzynowicz","year":"2019","unstructured":"Wegrzynowicz, M. et al. Depopulation of dense \u03b1-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson\u2019s disease model. Acta Neuropathol. 138, 575\u2013595 (2019).","journal-title":"Acta Neuropathol."},{"key":"1289_CR47","doi-asserted-by":"publisher","first-page":"114959","DOI":"10.1016\/j.expneurol.2024.114959","volume":"382","author":"SI Garcia Moreno","year":"2024","unstructured":"Garcia Moreno, S. I. et al. Viral overexpression of human alpha-synuclein in mouse substantia nigra dopamine neurons results in hyperdopaminergia but no neurodegeneration. Exp. Neurol. 382, 114959 (2024).","journal-title":"Exp. Neurol."},{"key":"1289_CR48","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/sj.gt.3300938","volume":"6","author":"S Zolotukhin","year":"1999","unstructured":"Zolotukhin, S. et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6, 973\u2013985 (1999).","journal-title":"Gene Ther."},{"key":"1289_CR49","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/laban0511-155","volume":"40","author":"T Yardeni","year":"2011","unstructured":"Yardeni, T., Eckhaus, M., Morris, H. D., Huizing, M. & Hoogstrate-Miller, S. Retro-orbital injections in mice. Lab. Anim. 40, 155\u2013160 (2011).","journal-title":"Lab. Anim."},{"key":"1289_CR50","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1038\/sj.gt.3301332","volume":"7","author":"M Mitchell","year":"2000","unstructured":"Mitchell, M., Jerebtsova, M., Batshaw, M. L., Newman, K. & Ye, X. Long-term transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors. Gene Ther. 7, 1986\u20131992 (2000).","journal-title":"Gene Ther."},{"key":"1289_CR51","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00467-005-1882-0","volume":"20","author":"M Jerebtsova","year":"2005","unstructured":"Jerebtsova, M., Liu, X.-H. & Ray, P. E. Adenovirus-mediated gene transfer to glomerular cells in newborn mice. Pediatr. Nephrol. 20, 1395\u20131400 (2005).","journal-title":"Pediatr. Nephrol."},{"key":"1289_CR52","first-page":"647","volume":"1","author":"T Knezevic","year":"2016","unstructured":"Knezevic, T. et al. Adeno-associated virus serotype 9-driven expression of BAG3 improves left ventricular dysfunction secondary to a myocardial infarction. JAAC Basic Transl. 1, 647\u2013656 (2016).","journal-title":"JAAC Basic Transl."},{"key":"1289_CR53","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1089\/hum.2017.037","volume":"28","author":"AM Gruntman","year":"2017","unstructured":"Gruntman, A. M., Su, L. & Flotte, T. R. Retro-orbital venous sinus delivery of rAAV9 mediates high-level transduction of brain and retina compared with temporal vein delivery in neonatal mouse pups. Hum. Gene Ther. 28, 228\u2013230 (2017).","journal-title":"Hum. Gene Ther."},{"key":"1289_CR54","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1538\/expanim.20-0186","volume":"70","author":"S Prabhakar","year":"2021","unstructured":"Prabhakar, S., Lule, S., Da Hora, C. C., Breakefield, X. O. & Cheah, P. S. AAV9 transduction mediated by systemic delivery of vector via retro-orbital injection in newborn, neonatal and juvenile mice. Exp. Anim. 70, 450\u2013458 (2021).","journal-title":"Exp. Anim."},{"key":"1289_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36324-3","volume":"14","author":"S Grodem","year":"2023","unstructured":"Grodem, S. et al. An updated suite of viral vectors for in vivo calcium imaging using intracerebral and retro-orbital injections in male mice. Nat. Commun. 14, 608 (2023).","journal-title":"Nat. Commun."},{"key":"1289_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-27372-8","volume":"13","author":"K Okamoto","year":"2023","unstructured":"Okamoto, K. et al. Specific AAV2\/PHP.eB-mediated gene transduction of CA2 pyramidal cells via injection into the lateral ventricle. Sci. Rep. 13, 323 (2023).","journal-title":"Sci. Rep."},{"key":"1289_CR57","doi-asserted-by":"publisher","first-page":"109931","DOI":"10.1016\/j.exer.2024.109931","volume":"244","author":"M Tang","year":"2024","unstructured":"Tang, M. et al. Efficient retinal ganglion cells transduction by retro-orbital venous sinus injection of AAV-PHP.eB in mature mice. Exp. Eye Res. 244, 109931 (2024).","journal-title":"Exp. Eye Res."},{"key":"1289_CR58","doi-asserted-by":"publisher","first-page":"1527858","DOI":"10.3389\/fimmu.2025.1527858","volume":"16","author":"W Li","year":"2025","unstructured":"Li, W. et al. Secreted PD-L1 alleviates inflammatory arthritis in mice through local and systemic AAV gene therapy. Front. Immunol. 16, 1527858 (2025).","journal-title":"Front. Immunol."},{"key":"1289_CR59","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11481-024-10164-4","volume":"20","author":"M Garcia-Gomara","year":"2024","unstructured":"Garcia-Gomara, M., Juan-Palencia, A., Alfaro, M., Cuadrado-Tejedor, M. & Garcia-Osta, A. Neuroprotective effects of dexamethasone in a neuromelanin-driven Parkinson\u2019s disease model. J. Neuroimmune Pharmacol. 20, 2 (2024).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"1289_CR60","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1111\/ejn.14129","volume":"48","author":"A-J Penttinen","year":"2018","unstructured":"Penttinen, A.-J. et al. Implementation of deep neural networks to count dopamine neurons in substantia nigra. Eur. J. Neurosci. 48, 2354\u20132361 (2018).","journal-title":"Eur. J. Neurosci."},{"key":"1289_CR61","first-page":"291","volume":"23","author":"AC Ruifrok","year":"2001","unstructured":"Ruifrok, A. C. & Johnston, D. A. Quantification of histochemical staining by color deconvolution. Anal. Quant. Cytol. Histol. 23, 291\u2013299 (2001).","journal-title":"Anal. Quant. Cytol. Histol."},{"key":"1289_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-0270(97)02226-7","volume":"74","author":"JL Lanciego","year":"1997","unstructured":"Lanciego, J. L., Goede, P. H., Witter, M. P. & Wouterlood, F. G. Use of peroxidase substrate vector VIP for multiple staining in light microscopy. J. Neurosci. Methods 74, 1\u20137 (1997).","journal-title":"J. Neurosci. Methods"},{"key":"1289_CR63","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s004180050361","volume":"111","author":"JL Lanciego","year":"1999","unstructured":"Lanciego, J. L. & Gim\u00e9nez-Amaya, J. M. Notes on the combined use of V-VIP and DAB peroxidase substrates for the detection of colocalising antigens. Histochem. Cell Biol. 111, 305\u2013311 (1999).","journal-title":"Histochem. Cell Biol."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01289-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01289-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01289-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T12:02:13Z","timestamp":1774008133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01289-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1289"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01289-9","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}